Effect of N-acetyl Cysteine versus placebo as adjunct therapy on the clinical outcomes in patients with chronic non-bacterial prostatitis

Phase 2

• Conditions: on-bacterial prostatitis.; Chronic prostatitis; N41.1

• Registration Number: IRCT20120215009014N318
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Age of 20 to 40 years,
Chronic non-bacterial prostatitis for at least 6 months,
The severity of the clinical symptoms at least 15 based on the NIH-CPSI questionnaire

Exclusion Criteria

Taking anti-androgen medications in the past 6 months,
Taking alpha-blockers or other antibiotics in the past month,
Taking antioxidant or anti-inflammatory or corticosteroids medications in the past month,
Genitourinary tract infection in the past 6 months,
Other diseases of the genitourinary system,
History of genitourinary system surgery,
Chronic liver or kidney disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The patient's clinical outcome. Timepoint: One, two, and three months after the intervention. Method of measurement: by using NIH-CPSI standard questionnaire.;The severity of pain. Timepoint: One, two, and three months after the intervention. Method of measurement: By using Visual Analog Scale (VAS).;The quality of urination. Timepoint: One, two, and three months after the intervention. Method of measurement: By taking history.